Calidi Biotherapeutics Announces Registered Direct Offering 1,025,640 Shares At $1.17 Per Share
The closing of the registered direct offering is expected to occur on or about September 18, 2026, subject to the satisfaction of customary closing conditions. The gross proceeds to Calidi from the registered direct
Calidi is selling new shares to raise cash for the company. When a company does this, watch if the stock price stays steady or drops after the sale.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.